alexa
Reach Us +44-1522-440391
GLOBAL BURDEN OF CHRONIC HEPATITIS B VIRUS INFECTION IN PRISON | 74465
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

GLOBAL BURDEN OF CHRONIC HEPATITIS B VIRUS INFECTION IN PRISON

6th International Conference on EPIDEMIOLOGY & PUBLIC HEALTH

Cristina Stasi

Regional Health Agency of Tuscany, Italy

Keynote: Epidemiology (Sunnyvale)

DOI: 10.4172/2161-1165-C1-016

Abstract
Statement of the Problem: Despite a vaccine against Hepatitis B Virus (HBV) has been available since 1982, the prevalence of adult with chronic HBV infection in sub-Saharan Africa and East Asia was estimated to be 5–10%. High rate of chronic infections is also found in the Amazon and the southern parts of eastern and central Europe. In the Middle East and the Indian subcontinent, the prevalence is of 2–5%. Less than 1% of the population of Western Europe and North America was chronically infected. Given the high prevalence of infections such as human immunodeficiency virus (HIV), HBV, and Hepatitis C Virus (HCV) among inmates, particularly those with a history of injection drug use, prison is considered reservoir facilitating these infections. The prevalence of HBsAg in prisoners in west and central Africa was very high (23.5%). High levels of chronic HBV infection were also reported in east and southern Africa (5.7%) and in Eastern Europe and central Asia (10.4%). Purpose: The purpose of this review is to analyse the most recent data on HBV prevalence and vaccination in prison. Methodology: Relevant studies were searched on PubMed database. The Centres for Disease Control and Prevention (CDC) has highlighted the importance of HBV blood screening and the subsequent anti-HBV vaccination in the prison population. The vaccination was recommended to all inmates and it represents an opportunity to prevent HBV infection in persons at high risk. In these subjects, an accelerated hepatitis B immunization schedule may result in a rapid seroconversion and practically in an early short-term protection. Conclusion & Significance: Although hepatitis B vaccination of inmates has been recommended since the vaccine first became available in 1982, only some state vaccinate inmates routinely. Therefore, it is necessary to have collaboration between public health, clinicians and correctional authorities to implement vaccination program.
Biography

Cristina Stasi graduated in Medicine and Surgery at the Catholic University of “Sacro Cuore”, Rome (2001). In 2006 she specialized in Gastroenterology at the University of Pisa. From 2006 to 2009 she took part in Clinical Research Projects at the University Hospital “Careggi”, Florence. At the same time, she improved her knowledge in Study Design, Management of Clinical Research Project, Statistics and Epidemiology. In 2013, she received her PhD in Experimental and Clinical Medicine from the University of Florence. She has published about 50 papers in reputed international journals and has been serving as an Editorial Board Member of some international journals.

Relevant Topics
Top